QHSLab, Inc.

Equities

USAQ

US90350R1077

Healthcare Facilities & Services

Market Closed - OTC Markets Other stock markets 10:16:07 2024-05-02 am EDT			5-day change	1st Jan Change
0.091 ^USD	-23.82%		+1.11%	+1.11%

Mar. 27	QHSLab, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 30	QHSLab, Inc. Integrates Digital Medicine Assessments into Prominent Electronic Health Record Company	CI

USA Equities Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021

November 15, 2021 at 04:20 pm EST

USA Equities Corp. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 0.324479 million. Net loss was USD 0.30077 million compared to USD 0.093448 million a year ago.
For the nine months, sales was USD 1.08 million. Net loss was USD 0.499783 million compared to USD 0.233717 million a year ago.

Latest news about QHSLab, Inc.

QHSLab, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
QHSLab, Inc. Integrates Digital Medicine Assessments into Prominent Electronic Health Record Company	Jan. 30	CI
Earnings Flash (USAQ) QHSLAB Reports Q3 Revenue $336,407	Nov. 14	MT
QHSLab, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
QHSLab, Inc. Welcomes Six New Integrated Service Program Customer Accounts and Launches Enhanced Website for Improved Customer Engagement	23-10-25	CI
QHSLab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
QHSLab, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
QHSLab, Inc. Auditor Raises 'Going Concern' Doubt	23-03-28	CI
QHSLab, Inc. Announces Representation Agreement with Healthcare Information Technology	23-02-16	CI
QHSLab, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force	22-11-01	CI
Qhslab, Inc. Launches A “Long Covid” Digital Health Tool for Primary Care Physicians	22-09-20	CI
QHSLab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
QHSLab, Inc. announced that it has received $0.4 million in funding from Mercer Street Capital Partners, LLC	22-07-25	CI
QHSLab, Inc. announced that it expects to receive $0.4 million in funding from Mercer Street Capital Partners, LLC	22-07-20	CI
QHSLab, Inc. Announces New Strategic Alliance with Medical License Factory, LLC for Its AllergiEnd Products and Services	22-06-24	CI
QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
USA Equities Corp. has Changed its Name to QHSLab, Inc	22-04-19	CI
USA Equities Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-01	CI
USA Equities Corp. Auditor Raises 'Going Concern' Doubt	22-03-31	CI
USA Equities Corp. has Changed its Name to QHSLab, Inc	22-01-18	CI
USA Equities Corp. Introduces AllergiQT?? Quick Test, Further Expanding Market Presence	21-11-29	CI
USA Equities Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
USA Equities Corp. Launches Q-Scale Product to Meet Growing Mental Health End Market Demand	21-10-19	CI

Chart QHSLab, Inc.

Duration

Period

More charts

Company Profile

QHSLab, Inc. is a medical device technology and software-as-a-service (SaaS) company. The Company focuses on enabling primary care physicians (PCPs) to increase their revenues by providing them with tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures. The products that the Company provides its physician clients enables them to diagnose and treat patients with chronic diseases The Company is engaged in providing PCPs with the software, training and devices necessary that allow them to treat their patients using value-based healthcare, informatics and algorithmic personalized medicine. Its digital healthcare, clinical decision support and point of care solutions also support non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and are reimbursable to medical practice.

Sector

Healthcare Facilities & Services

Calendar

2024-05-13 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
QHSLAB, INC.	+1.11%	1.22M
HCA HEALTHCARE, INC.	+14.10%	81.84B
CVS HEALTH CORPORATION	-30.15%	70.69B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+9.37%	29.03B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-11.90%	16.97B
FRESENIUS SE & CO. KGAA	-0.36%	16.83B
QUEST DIAGNOSTICS INCORPORATED	-1.12%	15.28B
FRESENIUS MEDICAL CARE AG	+5.90%	12.41B
DAVITA INC.	+35.78%	12.26B
EUROFINS SCIENTIFIC SE	-4.20%	11.86B

Other Healthcare Facilities & Services

QHSLab, Inc.

Equities

USAQ

US90350R1077

Healthcare Facilities & Services

USA Equities Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021

Latest news about QHSLab, Inc.

Chart QHSLab, Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Other Healthcare Facilities & Services